Anti-adhesion molecule therapies in inflammatory bowel disease: Touch and go
- 31 May 2008
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 7 (5), 364-369
- https://doi.org/10.1016/j.autrev.2008.01.002
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Repertoire-dependent immunopathologyJournal of Autoimmunity, 2007
- Innate and adaptive immune response to apoptotic cellsJournal of Autoimmunity, 2007
- Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel diseaseJCI Insight, 2007
- Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE TrialGastroenterology, 2007
- Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitisThe Journal of Experimental Medicine, 2006
- The role of very late antigen-1 in immune-mediated inflammationClinical Immunology, 2004
- Anti-inflammatory drugs and endothelial cell adhesion molecule expression in murine vascular bedsGut, 1999
- Critical role for β7 integrins in formation of the gut-associated lymphoid tissueNature, 1996
- P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin.The Journal of cell biology, 1995
- Distinct binding specificities of integrins α4β7 (LPAM-1), α4β1 (VLA-4), and αIELβ7International Immunology, 1994